Madeline B Deutsch

Madeline B Deutsch
University of California, San Francisco | UCSF · Department of Family and Community Medicine

About

38
Publications
20,585
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
2,221
Citations

Publications

Publications (38)
Article
Full-text available
The sexual partnerships of transmasculine (TM) adults—those assigned female at birth who identify as transgender men or a masculine spectrum gender identity—and characteristics associated with STI/HIV risk behavior remains understudied. Participants in the current study were TM adults (n = 141) receiving care at a community health center in Boston,...
Article
Objective To describe clinical characteristics and associated endometrial findings of transgender and gender nonbinary people using gender-affirming testosterone. Design Retrospective case series. Setting Academic medical center and public safety net hospital. Patient(s) Eighty-one patients using gender-affirming testosterone therapy undergoing...
Preprint
Full-text available
BACKGROUND Transgender and gender diverse (TGD) adults in the U.S. experience health disparities, especially in HIV infection. Medical gender affirmation such as hormone replacement therapy and gender-affirming surgeries is known to be medically necessary and to improve some health conditions. To our knowledge, however, no studies have assessed the...
Article
Background Transgender and gender diverse (TGD) adults in the United States experience health disparities, especially in HIV infection. Medical gender affirmation (eg, hormone therapy and gender-affirming surgeries) is known to be medically necessary and to improve some health conditions. To our knowledge, however, no studies have assessed the effe...
Article
Background Sex hormone and preexposure prophylaxis (PrEP) drug interactions among transgender women (TGW), transgender men (TGM), and cisgender men (CGM) are not fully understood. Methods TGM and TGW on at least 6 months of stable sex hormone therapy containing testosterone or estradiol (respectively) were enrolled in a 4-week study of directly ob...
Article
Full-text available
Introduction Evaluation of sexual functioning in transmasculine (TM) adults—those who identify as men, male, transmen, or non-binary yet were assigned a female sex at birth—is limited by lack of availability of brief screening measures. Aim Study aims were to (i) conduct initial psychometric evaluation of a brief screening tool to assess sexual fu...
Article
The sexual partnerships of transmasculine adults-who were assigned female at birth and identify on the masculine gender continuum-remain understudied. This includes characteristics of transmasculine adults' sexual partnerships associated with engaging in HIV/sexually transmitted infection (STI) sexual risk behavior. This study examined individual-...
Article
Background: Transgender men (TM) have a male, masculine, or non-female gender identity, yet were assigned female sex at birth on the basis of their external genitalia. The majority of TM are at-risk of infection with one of several high-risk strains of the human papillomavirus (hr-HPV), acquired primarily through sexual contact, that cause 99.7% o...
Article
Full-text available
Objectives: This study aims to identify factors associated with the reproductive planning of trans-masculine adults. Study design: Between 2015 and 2016, providers enrolled 150 trans-masculine adults in a sexual health study assessing sociodemographics, social support, gender affirmation, sexual partnering, and reproductive history and planning....
Article
Intimate partner violence (IPV) takes on unique dimensions when directed against transgender individuals, with perpetrators leveraging transphobia to assert power and control. Standard IPV measurement tools do not assess this type of IPV. Four questions to assess transgender-related IPV (T-IPV) were developed: (a) being forced to conform to an unde...
Article
Full-text available
Background: High-risk human papillomavirus (hrHPV) causes virtually all cervical cancers. Trans masculine (TM) people (those assigned female at birth who identify with a gender other than female) have low uptake of conventional cervical cancer screening. Self-collected hrHPV DNA testing has high levels of acceptability among cisgender (non-transge...
Article
Full-text available
Background Cervical cancer, nearly all cases of which are caused by one of several high-risk strains of the human papillomavirus (hr-HPV), leads to significant morbidity and mortality in individuals with a cervix. Trans masculine (TM) individuals were born with female reproductive organs and identify as male, man, transgender man, or another divers...
Article
Full-text available
Introduction Globally, transgender (“trans”) women are one of the key populations most disproportionately impacted by HIV. Pre-exposure prophylaxis (PrEP) is the newest and most promising biomedical HIV prevention intervention to date. This paper reviews relevant literature to describe the current state of the science and describes the potential ro...
Article
Full-text available
Abstract: Transgender (trans) communities worldwide, particularly those on the trans feminine spectrum, are disproportionately burdened by HIV infection and at risk for HIV acquisition/transmission. Trans individuals represent an underserved, highly stigmatized, and under-resourced population not only in HIV prevention efforts but also in delivery...
Article
Full-text available
Lessons were learned with trans women who participated (as volunteers and investigators) in trials of HIV pre-exposure prophylaxis (PrEP). Trans women are not men. Compared with men who have sex with men, trans women trial participants were more likely to be involved with transactional sex, had more sexual partners, and were less likely to have PrE...
Article
Full-text available
Introduction Studies have shown that transgender women (TGW) are disproportionately affected by HIV, with an estimated HIV prevalence of 19.1% among TGW worldwide. After receiving a diagnosis, HIV-positive TGW have challenges accessing effective HIV treatment, as demonstrated by lower rates of virologic suppression and higher HIV-related mortality....
Article
Full-text available
Purpose of review: This article describes methodological challenges, gaps, and opportunities in US transgender health research. Recent findings: Lack of large prospective observational studies and intervention trials, limited data on risks and benefits of sex affirmation (e.g., hormones and surgical interventions), and inconsistent use of defini...
Article
Full-text available
Purpose of review: Research on the health of transgender and gender nonconforming people has been limited with most of the work focusing on transition-related care and HIV. The present review summarizes research to date on the overall development and quality of life of transgender and gender nonconforming adults, and makes recommendations for futu...
Article
Full-text available
Final rules issued by the Centers for Medicare and Medicaid Services and the Office of the National Coordinator for Health Information Technology in October 2015 require electronic health record software certified for Meaningful Use to include sexual orientation and gender identity (SO/GI) fields. This is a critical step toward making SO/GI data co...
Article
Full-text available
Background Oral emtricitabine-tenofovir disoproxil fumarate (FTC/TDF) pre-exposure prophylaxis (PrEP) is used to prevent the sexual acquisition of HIV. Transgender women (TGW) have unique characteristics that may relate to PrEP use, effectiveness, and safety. Methods The iPrEx trial was a randomized controlled trial (RCT) of oral FTC/TDF PrEP vers...
Article
To describe weight, body mass index (BMI), blood pressure (BP), lipids, and hormone levels in transgender women and men presenting for initiation of cross-sex hormone therapy at a community clinic in the United States. Twenty-three transgender women (persons assigned male at birth who identify as female and want to use estrogen to develop female se...
Article
Transgender (Trans, Trans*) persons may have a gender identity and a preferred name that differ from those assigned at birth, and/or those listed on their current legal identification (Gender ID, Birth-assigned Sex, Legal Sex). Transgender people who are referred to in a clinical setting using the wrong pronoun or name may suffer distress, ridicule...
Conference Paper
Full-text available
INTRODUCTION: Transgender (trans) individuals experience significant health disparities due to stigma and discrimination in healthcare settings. Consequently, they often avoid Emergency Departments (ED) and delay seeking care. Studies examining attitudes and preparedness of ED providers regarding trans healthcare are lacking. OBJECTIVES: This pil...
Article
Full-text available
Worldwide, transgender women who engage in sex work have a disproportionate risk for HIV compared with natal male and female sex workers. We reviewed recent epidemiological research on HIV in transgender women and show that transgender women sex workers (TSW) face unique structural, interpersonal, and individual vulnerabilities that contribute to r...
Article
Full-text available
Transgender, transsexual, or transitioned (trans) people have reported avoiding medical care because of negative experiences or fear of such experiences. The extent of trans-specific negative emergency department (ED) experiences, and of ED avoidance, has not been documented. The Trans PULSE Project conducted a survey of trans people in Ontario, Ca...
Article
Full-text available
Transgender patients have particular needs with respect to demographic information and health records; specifically, transgender patients may have a chosen name and gender identity that differs from their current legally designated name and sex. Additionally, sex-specific health information, for example, a man with a cervix or a woman with a prosta...
Article
Introduction: Some clinics have developed models for the initiation of cross sex hormone therapy (csHT) without an in-depth mental health evaluation and referral. These approaches have also been referred to as the informed consent (IC) model.Aims: (a) Survey practice characteristics of clinics utilizing the IC care model; (b) assess potential legal...

Network

Cited By

Projects

Projects (2)
Project
My intention with this project in the context of ResearchGate is to provide a place for researchers to locate official statements from WPATH that comment on issues that are not directly covered in the WPATH Standards of Care, and to document the historical evolution of relevant guidelines. Some researchers have added papers that are relevant to aspects of transgender health, but this project is less about clinical experience, and more about the overarching policy positions that are grounded in the WPATH Standards of Care, which is an evolving document itself. I have been the author of most of WPATH's policy statements (which are approved by the WPATH Board of Directors) since the organization began issuing them in 2008. Sometimes I have originated the statement by making the case for its importance with the Board, and sometimes other board members will bring the issue up, and assist in or lead the drafting of the final statement. Researchers who are looking for places to gain wider readership for their publications are advised to link their articles via keywords related to transgender health so they may be located by search engines rather than place them under the "umbrella" of this particular project.
Project
Trans-specific PrEP demonstration projects at two community-based clinics, La Clinica de la Raza in Oakland and Gender Health Center in Sacramento.